US Stock MarketDetailed Quotes

CTSO Cytosorbents

Watchlist
  • 0.8700
  • -0.0001-0.01%
Close May 13 16:00 ET
  • 0.9000
  • +0.0300+3.45%
Post 20:01 ET
54.47MMarket Cap-2.29P/E (TTM)

Cytosorbents Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
14.51%35.59M
24.52%9.15M
11.08%8.61M
9.53%8.84M
13.65%8.99M
5.88%31.08M
-3.84%7.35M
19.98%7.75M
10.12%8.07M
-0.18%7.91M
Operating revenue
14.51%35.59M
24.52%9.15M
11.08%8.61M
9.53%8.84M
13.65%8.99M
5.88%31.08M
-3.84%7.35M
19.98%7.75M
10.12%8.07M
-0.18%7.91M
Cost of revenue
14.64%10.47M
83.12%-247.87K
28.24%4.11M
-0.30%3.39M
-19.49%3.22M
-34.57%9.13M
-140.42%-1.47M
-28.70%3.2M
-4.18%3.4M
75.36%3.99M
Gross profit
14.45%25.13M
6.59%9.4M
-1.01%4.5M
16.70%5.45M
47.45%5.77M
42.52%21.95M
119.96%8.82M
131.12%4.55M
23.55%4.67M
-30.65%3.92M
Operating expense
-22.24%41.91M
-28.86%13.44M
-25.21%8.9M
-21.02%8.87M
-9.39%10.7M
14.87%53.9M
82.33%18.9M
8.32%11.9M
-7.48%11.23M
-12.13%11.81M
Selling and administrative expenses
-8.64%35M
-13.39%9.52M
-15.00%7.83M
-5.69%8.4M
1.26%9.25M
3.15%38.31M
26.17%10.99M
-1.46%9.21M
-2.30%8.91M
-8.32%9.13M
-General and administrative expense
----
----
-15.00%7.83M
-5.69%8.4M
1.26%9.25M
----
----
-1.46%9.21M
-2.30%8.91M
-8.32%9.13M
Research and development costs
-55.65%6.92M
-67.26%1.3M
-50.62%1.85M
-58.58%1.52M
-46.65%2.25M
3.15%15.59M
16.46%3.96M
13.95%3.75M
-12.30%3.67M
-0.68%4.21M
Other operating expenses
----
----
26.42%-777.59K
21.92%-1.05M
48.24%-796.77K
----
----
35.90%-1.06M
-15.76%-1.35M
-100.72%-1.54M
Operating profit
47.46%-16.79M
59.87%-4.05M
40.19%-4.4M
47.88%-3.42M
37.59%-4.93M
-1.35%-31.95M
-58.59%-10.08M
18.49%-7.35M
21.51%-6.56M
-1.29%-7.89M
Net non-operating interest income expense
-786.11%-1.4M
-1,095.10%-624.19K
-1,646.82%-588.15K
-1,941.70%-180.1K
89.47%-6.65K
-219.08%-157.89K
-197.17%-52.23K
-171.88%-33.67K
-136.80%-8.82K
-886.97%-63.17K
Non-operating interest expense
786.11%1.4M
1,095.10%624.19K
1,646.82%588.15K
----
----
--157.89K
--52.23K
--33.67K
----
----
Total other finance cost
----
----
----
1,941.70%180.1K
-89.47%6.65K
----
----
----
136.80%8.82K
886.97%63.17K
Other net income (expense)
-306.49%-4.22M
-278.69%-4.91M
246.45%2.65M
-231.15%-544.23K
-326.70%-1.43M
181.32%2.05M
-38.23%2.75M
43.98%-1.81M
116.30%414.97K
153.15%628.88K
Gain on sale of security
-316.73%-4.22M
-282.80%-4.91M
246.45%2.65M
-231.15%-544.23K
-315.79%-1.43M
179.61%1.95M
-40.61%2.68M
43.98%-1.81M
116.45%414.97K
154.45%660.68K
Other non- operating income (expenses)
-100.03%-30
----
----
----
----
243.76%96.76K
183.30%61.76K
----
----
-205.99%-31.8K
Income before tax
25.45%-22.41M
-29.60%-9.57M
74.61%-2.33M
32.67%-4.14M
13.21%-6.36M
11.34%-30.06M
-297.48%-7.39M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
Income tax
-107.78%-1.69M
-107.78%-1.69M
0
0
0
25.52%-813.74K
25.52%-813.74K
0
0
0
Net income
29.16%-20.72M
-19.92%-7.88M
74.61%-2.33M
32.67%-4.14M
13.21%-6.36M
10.87%-29.25M
-758.12%-6.57M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
Net income continuous Operations
29.16%-20.72M
-19.92%-7.88M
74.61%-2.33M
32.67%-4.14M
13.21%-6.36M
10.87%-29.25M
-758.12%-6.57M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
Minority interest income
Net income attributable to the parent company
29.16%-20.72M
-19.92%-7.88M
74.61%-2.33M
32.67%-4.14M
13.21%-6.36M
10.87%-29.25M
-758.12%-6.57M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
29.16%-20.72M
-19.92%-7.88M
74.61%-2.33M
32.67%-4.14M
13.21%-6.36M
10.87%-29.25M
-758.12%-6.57M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
Basic earnings per share
41.54%-0.38
-5.60%-0.14
80.95%-0.0398
42.86%-0.0796
29.41%-0.1194
12.90%-0.65
-1,232.40%-0.1326
25.00%-0.209
44.00%-0.1393
19.05%-0.1692
Diluted earnings per share
41.54%-0.38
-5.60%-0.14
80.95%-0.0398
42.86%-0.0796
29.41%-0.1194
12.90%-0.65
-1,232.40%-0.1326
25.00%-0.209
44.00%-0.1393
19.05%-0.1692
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 14.51%35.59M24.52%9.15M11.08%8.61M9.53%8.84M13.65%8.99M5.88%31.08M-3.84%7.35M19.98%7.75M10.12%8.07M-0.18%7.91M
Operating revenue 14.51%35.59M24.52%9.15M11.08%8.61M9.53%8.84M13.65%8.99M5.88%31.08M-3.84%7.35M19.98%7.75M10.12%8.07M-0.18%7.91M
Cost of revenue 14.64%10.47M83.12%-247.87K28.24%4.11M-0.30%3.39M-19.49%3.22M-34.57%9.13M-140.42%-1.47M-28.70%3.2M-4.18%3.4M75.36%3.99M
Gross profit 14.45%25.13M6.59%9.4M-1.01%4.5M16.70%5.45M47.45%5.77M42.52%21.95M119.96%8.82M131.12%4.55M23.55%4.67M-30.65%3.92M
Operating expense -22.24%41.91M-28.86%13.44M-25.21%8.9M-21.02%8.87M-9.39%10.7M14.87%53.9M82.33%18.9M8.32%11.9M-7.48%11.23M-12.13%11.81M
Selling and administrative expenses -8.64%35M-13.39%9.52M-15.00%7.83M-5.69%8.4M1.26%9.25M3.15%38.31M26.17%10.99M-1.46%9.21M-2.30%8.91M-8.32%9.13M
-General and administrative expense ---------15.00%7.83M-5.69%8.4M1.26%9.25M---------1.46%9.21M-2.30%8.91M-8.32%9.13M
Research and development costs -55.65%6.92M-67.26%1.3M-50.62%1.85M-58.58%1.52M-46.65%2.25M3.15%15.59M16.46%3.96M13.95%3.75M-12.30%3.67M-0.68%4.21M
Other operating expenses --------26.42%-777.59K21.92%-1.05M48.24%-796.77K--------35.90%-1.06M-15.76%-1.35M-100.72%-1.54M
Operating profit 47.46%-16.79M59.87%-4.05M40.19%-4.4M47.88%-3.42M37.59%-4.93M-1.35%-31.95M-58.59%-10.08M18.49%-7.35M21.51%-6.56M-1.29%-7.89M
Net non-operating interest income expense -786.11%-1.4M-1,095.10%-624.19K-1,646.82%-588.15K-1,941.70%-180.1K89.47%-6.65K-219.08%-157.89K-197.17%-52.23K-171.88%-33.67K-136.80%-8.82K-886.97%-63.17K
Non-operating interest expense 786.11%1.4M1,095.10%624.19K1,646.82%588.15K----------157.89K--52.23K--33.67K--------
Total other finance cost ------------1,941.70%180.1K-89.47%6.65K------------136.80%8.82K886.97%63.17K
Other net income (expense) -306.49%-4.22M-278.69%-4.91M246.45%2.65M-231.15%-544.23K-326.70%-1.43M181.32%2.05M-38.23%2.75M43.98%-1.81M116.30%414.97K153.15%628.88K
Gain on sale of security -316.73%-4.22M-282.80%-4.91M246.45%2.65M-231.15%-544.23K-315.79%-1.43M179.61%1.95M-40.61%2.68M43.98%-1.81M116.45%414.97K154.45%660.68K
Other non- operating income (expenses) -100.03%-30----------------243.76%96.76K183.30%61.76K---------205.99%-31.8K
Income before tax 25.45%-22.41M-29.60%-9.57M74.61%-2.33M32.67%-4.14M13.21%-6.36M11.34%-30.06M-297.48%-7.39M24.65%-9.19M43.44%-6.15M18.30%-7.33M
Income tax -107.78%-1.69M-107.78%-1.69M00025.52%-813.74K25.52%-813.74K000
Net income 29.16%-20.72M-19.92%-7.88M74.61%-2.33M32.67%-4.14M13.21%-6.36M10.87%-29.25M-758.12%-6.57M24.65%-9.19M43.44%-6.15M18.30%-7.33M
Net income continuous Operations 29.16%-20.72M-19.92%-7.88M74.61%-2.33M32.67%-4.14M13.21%-6.36M10.87%-29.25M-758.12%-6.57M24.65%-9.19M43.44%-6.15M18.30%-7.33M
Minority interest income
Net income attributable to the parent company 29.16%-20.72M-19.92%-7.88M74.61%-2.33M32.67%-4.14M13.21%-6.36M10.87%-29.25M-758.12%-6.57M24.65%-9.19M43.44%-6.15M18.30%-7.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 29.16%-20.72M-19.92%-7.88M74.61%-2.33M32.67%-4.14M13.21%-6.36M10.87%-29.25M-758.12%-6.57M24.65%-9.19M43.44%-6.15M18.30%-7.33M
Basic earnings per share 41.54%-0.38-5.60%-0.1480.95%-0.039842.86%-0.079629.41%-0.119412.90%-0.65-1,232.40%-0.132625.00%-0.20944.00%-0.139319.05%-0.1692
Diluted earnings per share 41.54%-0.38-5.60%-0.1480.95%-0.039842.86%-0.079629.41%-0.119412.90%-0.65-1,232.40%-0.132625.00%-0.20944.00%-0.139319.05%-0.1692
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Coinbase
COIN
256.900
Tesla
TSLA
334.070
Strategy
MSTR
421.610
4
Ecopetrol
EC
8.620
5
Oracle
ORCL
162.270
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀